Stay updated on Selumetinib with Vinblastine in Low-Grade Glioma Clinical Trial
Sign up to get notified when there's something new on the Selumetinib with Vinblastine in Low-Grade Glioma Clinical Trial page.

Latest updates to the Selumetinib with Vinblastine in Low-Grade Glioma Clinical Trial page
- ChecktodayChange DetectedThe page revision/version indicator was updated from v3.5.2 to v3.5.3, reflecting a maintenance release of the site rather than any change to the clinical trial record content.SummaryDifference0.0%

- Check7 days agoChange DetectedAdded 2026-04-13 Revision: v3.5.2 and removed 2026-04-08 Revision: v3.5.0.SummaryDifference0.1%

- Check14 days agoChange DetectedTwo new study record update dates (April 8 and April 9, 2026) were added, and two earlier dates (April 2 and April 3, 2026) were removed.SummaryDifference0.1%

- Check22 days agoChange DetectedTwo new update dates (2026-04-02 and 2026-04-03) were added to the study record history, reflecting recent page updates.SummaryDifference0.1%

- Check29 days agoChange DetectedThe Study Record Dates were updated to include new entries dated 2026-03-27 and 2026-03-26, and to remove entries dated 2026-03-20 and 2026-03-19.SummaryDifference0.1%

- Check36 days agoChange DetectedAdditions indicate dates 2026-03-19 and 2026-03-20 with Revision: v3.5.0; deletions indicate dates 2026-03-12 and 2026-03-13 with Revision: v3.4.3.SummaryDifference0.1%

Stay in the know with updates to Selumetinib with Vinblastine in Low-Grade Glioma Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Selumetinib with Vinblastine in Low-Grade Glioma Clinical Trial page.